Reply to: Optimizing DeepHRD Interpretability for Enhanced Clinical Decision Making

Affiliation

• ¹ Erik N. Bergstrom, PhD, Moores Cancer Center, UC San Diego, La Jolla, CA, Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA, Department of Bioengineering, UC San Diego, La Jolla, CA; Scott M. Lippman, MD, Moores Cancer Center, UC San Diego, La Jolla, CA; and Ludmil B. Alexandrov, PhD, Moores Cancer Center, UC San Diego, La Jolla, CA, Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA, Department of Bioengineering, UC San Diego, La Jolla, CA, Sanford Stem Cell Institute, University of California San Diego, La Jolla, CA.